The challenged biotech firm, NovaGen Therapeutics, faced significant monetary difficulties stemming from disappointing clinical trials and mounting debt. Their internal leadership lacked the expertise to https://siobhanhiuo942979.aboutyoublog.com/52598428/biotech-cfo-services-a-case-study-in-financial-restructuring